Intraoperative Pharmacotherapeutic Blood Management Strategies in Total Knee Arthroplasty

Abstract

Bone and soft tissue bleeding often results in substantial amounts of blood loss following total knee arthroplasty. Multiple studies have reported that cumulative blood loss varies between 500 and 1,500 mL in primary settings. Increased perioperative blood loss frequently requires allogeneic blood transfusions to improve the hematocrit and the hemoglobin levels. However, allogeneic transfusion is associated with risks of immunosuppression, transfusion reactions, graft versus host disease, and transmission of infections. To avoid these problems and reduce costs of transfusion, multiple intraoperative pharmacotherapeutic strategies have been developed. The various pharmacotherapeutic agents currently used are tranexamic acid, epsilon-aminocaproic acid, fibrin, thrombin, lavage with epinephrine, and norepinephrine. However, the relative efficacy and the cost-effectiveness of these techniques may vary. Thus, the purpose of this study was to provide a brief overview of the relative efficacy of various intraoperative pharmacological methods currently in use for decreasing blood loss following total knee arthroplasty and describe their potential complications associated with their use.

Keywords

blood - loss - prevention - pharmacotherapy - knee - arthroplasty

• References

• 1 Berman AT, Geissele AE, Bosacco SJ. Blood loss with total knee arthroplasty. Clin Orthop Relat Res 1988; (234) 137-138
• 2 Hays MB, Mayfield JF. Total blood loss in major joint arthroplasty. A comparison of cemented and noncemented hip and knee operations. J Arthroplasty 1988; 3 (Suppl): S47-S49
• 3 Rosencher N, Kerkkamp HE, Macheras G , et al; OSTHEO Investigation. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43 (4) 459-469
• 4 Lotke PA, Faralli VJ, Orenstein EM, Ecker ML. Blood loss after total knee replacement. Effects of tourniquet release and continuous passive motion. J Bone Joint Surg Am 1991; 73 (7) 1037-1040
• 5 Sehat KR, Evans R, Newman JH. How much blood is really lost in total knee arthroplasty? Correct blood loss management should take hidden loss into account. Knee 2000; 7 (3) 151-155
• 6 Jämsen E, Puolakka T, Eskelinen A , et al. Predictors of mortality following primary hip and knee replacement in the aged. A single-center analysis of 1,998 primary hip and knee replacements for primary osteoarthritis. Acta Orthop 2013; 84 (1) 44-53
• 7 Spahn DR. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 2010; 113 (2) 482-495
• 8 Patel KK, Patel AK, Ranjan RR, Shah AP. Transfusion associated graft versus host disease following whole blood transfusion from an unrelated donor in an immunocompetent patient. Indian J Hematol Blood Transfus 2010; 26 (3) 92-95
• 9 Heddle NM. Pathophysiology of febrile nonhemolytic transfusion reactions. Curr Opin Hematol 1999; 6 (6) 420-426
• 10 Sharma S, Sharma P, Tyler LN. Transfusion of blood and blood products: indications and complications. Am Fam Physician 2011; 83 (6) 719-724
• 11 Eder AF, Chambers LA. Noninfectious complications of blood transfusion. Arch Pathol Lab Med 2007; 131 (5) 708-718
• 12 Auroy Y, Lienhart A, Péquignot F, Benhamou D. Complications related to blood transfusion in surgical patients: data from the French national survey on anesthesia-related deaths. Transfusion 2007; 47 (2) (Suppl): 184S-189S , discussion 201S
• 13 Vamvakas EC, Moore SB, Cabanela M. Blood transfusion and septic complications after hip replacement surgery. Transfusion 1995; 35 (2) 150-156
• 14 Irisson E, Hémon Y, Pauly V, Parratte S, Argenson JN, Kerbaul F. Tranexamic acid reduces blood loss and financial cost in primary total hip and knee replacement surgery. Orthop Traumatol Surg Res 2012; 98 (5) 477-483
• 15 Sepah YJ, Umer M, Ahmad T, Nasim F, Chaudhry MU, Umar M. Use of tranexamic acid is a cost effective method in preventing blood loss during and after total knee replacement. J Orthop Surg 2011; 6: 22
• 16 Muñoz M, García-Erce JA, Cuenca J. Tranexamic acid for reducing transfusion requirements after total knee arthroplasty: can efficacy and cost ratios be improved?. Vox Sang 2008; 95 (4) 350-351 , author reply 352
• 17 Bernasek TL, Burris RB, Fujii H, Levering MF, Polikandriotis JA, Patterson JJ. Effect on blood loss and cost-effectiveness of pain cocktails, platelet-rich plasma, or fibrin sealant after total knee arthroplasty. J Arthroplasty 2012; 27 (8) 1448-1451
• 18 Vigna-Taglianti F, Basso L, Rolfo P , et al. Tranexamic acid for reducing blood transfusions in arthroplasty interventions: a cost-effective practice. Eur J Orthop Surg Traumatol 2013; (Apr) 30
• 19 Tai TW, Chang CW, Lai KA, Lin CJ, Yang CY. Effects of tourniquet use on blood loss and soft-tissue damage in total knee arthroplasty: a randomized controlled trial. J Bone Joint Surg Am 2012; 94 (24) 2209-2215
• 20 Alcelik I, Pollock RD, Sukeik M, Bettany-Saltikov J, Armstrong PM, Fismer P. A comparison of outcomes with and without a tourniquet in total knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials. J Arthroplasty 2012; 27 (3) 331-340
• 21 Harvey EJ, Leclerc J, Brooks CE, Burke DL. Effect of tourniquet use on blood loss and incidence of deep vein thrombosis in total knee arthroplasty. J Arthroplasty 1997; 12 (3) 291-296
• 22 Stroh DA, Johnson AJ, Mont MA, Bonutti PM. Excellent clinical outcomes in total knee arthroplasty performed without a tourniquet. Surg Technol Int 2011; XXI: 189-193
• 23 Juelsgaard P, Møller M, Larsen U. Preoperative Acute Normovolaemic Hemodilution (ANH) in combination with Hypotensive Epidural Anaesthesia (HEA) during knee arthroplasty surgery. No effect on transfusion rate. A randomized controlled trial [ISRCTN87597684]. BMC Anesthesiol 2002; 2 (1) 1
• 24 Kiss H, Raffl M, Neumann D, Hutter J, Dorn U. Epinephrine-augmented hypotensive epidural anesthesia replaces tourniquet use in total knee replacement. Clin Orthop Relat Res 2005; (436) 184-189
• 25 Umlas J, Jacobson MS, Kevy SV. Survival and half-life of red cells salvaged after hip and knee replacement surgery. Transfusion 1993; 33 (7) 591-593
• 26 Rizzi L, Bertacchi P, Ghezzi LM, Bellavita P, Scudeller G. Postoperative blood salvage in hip and knee arthroplasty. A prospective study on cost effectiveness in 161 patients. Acta Orthop Scand 1998; 69 (1) 31-34
• 27 Newman JH, Bowers M, Murphy J. The clinical advantages of autologous transfusion. A randomized, controlled study after knee replacement. J Bone Joint Surg Br 1997; 79 (4) 630-632
• 28 Singh VK, Singh PK, Javed S, Kumar K, Tomar J. Autologous transfusion of drain contents in elective primary knee arthroplasty: its value and relevance. Blood Transfus 2011; 9 (3) 281-285
• 29 Sarkanović ML, Gvozdenović L, Savić D, Ilić MP, Jovanović G. Autologous blood transfusion in total knee replacement surgery. Vojnosanit Pregl 2013; 70 (3) 274-278
• 30 Park KH, Lee SR, Jin JM, Moon MS. The efficacy and safety of postoperative autologous transfusion of filtered shed blood and anticoagulant prophylaxis in total knee arthroplasty patients. Knee Surg Relat Res 2012; 24 (1) 14-18
• 31 Tellisi N, Kakwani R, Hulse N, Abusitta G, Ashammakhi N, Wahab KA. Autologous blood transfusion following total knee arthroplasty: is it always necessary?. Int Orthop 2006; 30 (5) 412-414
• 32 Harwin SF, Issa K, Naziri Q, Pivec R, Johnson AJ, Mont MA. Excellent Results of Revision TKA in Jehovah's Witness Patients. J Knee Surg 2012; (Sep) 21
• 33 Tzonos T, Giromini D. Aprotinin for intraoperative haemostasis. Neurosurg Rev 1981; 4 (4) 193-194
• 34 Kim TK, Chang CB, Koh IJ. Practical issues for the use of tranexamic acid in total knee arthroplasty: a systematic review. Knee Surg Sports Traumatol Arthrosc 2013; (Mar) 31
• 35 Gillette BP, DeSimone LJ, Trousdale RT, Pagnano MW, Sierra RJ. Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty. Clin Orthop Relat Res 2013; 471 (1) 150-154
• 36 Zhang H, Chen J, Chen F, Que W. The effect of tranexamic acid on blood loss and use of blood products in total knee arthroplasty: a meta-analysis. Knee Surg Sports Traumatol Arthrosc 2012; 20 (9) 1742-1752
• 37 Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, Lim W. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 2009; 123 (5) 687-696
• 38 Onodera T, Majima T, Sawaguchi N, Kasahara Y, Ishigaki T, Minami A. Risk of deep venous thrombosis in drain clamping with tranexamic acid and carbazochrome sodium sulfonate hydrate in total knee arthroplasty. J Arthroplasty 2012; 27 (1) 105-108
• 39 Sundström A, Seaman H, Kieler H, Alfredsson L. The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database. BJOG 2009; 116 (1) 91-97
• 40 Camarasa MA, Olle G, Serra-Prat M , et al. Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth 2006; 96 (5) 576-582
• 41 Sabatini L, Trecci A, Imarisio D, Uslenghi MD, Bianco G, Scagnelli R. Fibrin tissue adhesive reduces postoperative blood loss in total knee arthroplasty. J Orthop Traumatol 2012; 13 (3) 145-151
• 42 Molloy DO, Archbold HA, Ogonda L, McConway J, Wilson RK, Beverland DE. Comparison of topical fibrin spray and tranexamic acid on blood loss after total knee replacement: a prospective, randomised controlled trial. J Bone Joint Surg Br 2007; 89 (3) 306-309
• 43 Wang GJ, Hungerford DS, Savory CG , et al. Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J Bone Joint Surg Am 2001; 83-A (10) 1503-1505
• 44 Notarnicola A, Moretti L, Martucci A , et al. Comparative efficacy of different doses of fibrin sealant to reduce bleeding after total knee arthroplasty. Blood Coagul Fibrinolysis 2012; 23 (4) 278-284
• 45 Anderson LA, Engel GM, Bruckner JD, Stoddard GJ, Peters CL. Reduced blood loss after total knee arthroplasty with local injection of bupivacaine and epinephrine. J Knee Surg 2009; 22 (2) 130-136
• 46 Lombardi Jr AV, Berend KR, Mallory TH, Dodds KL, Adams JB. Soft tissue and intra-articular injection of bupivacaine, epinephrine, and morphine has a beneficial effect after total knee arthroplasty. Clin Orthop Relat Res 2004; (428) 125-130
• 47 Risberg B. The response of the fibrinolytic system in trauma. Acta Chir Scand Suppl 1985; 522: 245-271
• 48 Umanskiĭ MA. [Mechanisms of the activation of the fibrinolytic system during surgical operations]. Probl Gematol Pereliv Krovi 1971; 16 (8) 33-37
• 49 Raza I, Davenport R, Rourke C , et al. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 2013; 11 (2) 307-314
• 50 Andersson L, Nilsson IM, Olow B. Fibrinolytic activity in man during surgery. Thromb Diath Haemorrh 1962; 7: 391-403
• 51 Murakami F. [Significance of fibrinolytic enzymes in surgery]. Chiryo 1962; 44: 2155-2165
• 52 Samama M, Weiss M, Yver J, Dubost C, Marchal G. [Fibrinolytic hyperactivity in 280 open-heart surgery patients. Clinical correlations and therapeutic results]. Transfusion (Paris) 1963; 6: 459-464
• 53 Trinidad JC. Fibrinolytic Hemorrhage in General Surgery. Philipp J Surg Surg Spec 1963; 18: 197-202
• 54 McNicol GP, Douglas AS. Acute Fibrinolytic States in Surgery. Proc R Soc Med 1965; 58: 259-261
• 55 Kinzel V, Shakespeare D, Derbyshire D. The effect of aprotinin on blood loss in bilateral total knee arthroplasty. Knee 2005; 12 (2) 107-111
• 56 Opella SJ, Wise WB, DiVerdi JA. Deoxyribonucleic acid dynamics from phosphorus-31 nuclear magnetic resonance. Biochemistry 1981; 20 (2) 284-290
• 57 Allison PM, Whitten CW. What is the mechanism of action of aprotinin?. Anesthesiology 1991; 75 (2) 377-379
• 58 Fussi F. Aprotinin: mechanism of action and therapeutical uses. Boll Chim Farm 1980; 119 (11) 631-646
• 59 Deysine M, Cliffton EE. Mechanism of Action of Epsilon Aminocaproic Acid in the Control of Hemorrhage. Ann N Y Acad Sci 1964; 115: 291-297
• 60 Lukasiewicz H, Niewiarowski S. In vivo studies on the mechanism of the antifibrinolytic action of E-aminocaproic acid (EACA). Thromb Diath Haemorrh 1968; 19 (3) 584-592
• 61 Huang H, Ding W, Su Z, Zhang W. Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery. J Thorac Cardiovasc Surg 1993; 106 (1) 11-18
• 62 Hoylaerts M, Lijnen HR, Collen D. Studies on the mechanism of the antifibrinolytic action of tranexamic acid. Biochim Biophys Acta 1981; 673 (1) 75-85
• 63 Thorpe CM, Murphy WG, Logan M. Use of aprotinin in knee replacement surgery. Br J Anaesth 1994; 73 (3) 408-410
• 64 Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM. Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br 2011; 93 (12) 1577-1585
• 65 Odabaş AR, Cetinkaya R, Selçuk Y, Kaya H, Coşkun U. Tranexamic-acid-induced acute renal cortical necrosis in a patient with haemophilia A. Nephrol Dial Transplant 2001; 16 (1) 189-190
• 66 Martin K, Knorr J, Breuer T , et al. Seizures after open heart surgery: comparison of ε-aminocaproic acid and tranexamic acid. J Cardiothorac Vasc Anesth 2011; 25 (1) 20-25
• 67 Andersson L, Eriksson O, Hedlund PO, Kjellman H, Lindqvist B. Special considerations with regard to the dosage of tranexamic acid in patients with chronic renal diseases. Urol Res 1978; 6 (2) 83-88
• 68 Manji RA, Grocott HP, Leake J , et al. Seizures following cardiac surgery: the impact of tranexamic acid and other risk factors. Can J Anaesth 2012; 59 (1) 6-13
• 69 Manjunath G, Fozailoff A, Mitcheson D, Sarnak MJ. Epsilon-aminocaproic acid and renal complications: case report and review of the literature. Clin Nephrol 2002; 58 (1) 63-67
• 70 Liskiewicz Z, Maj S, Ziemski JM. [Renal complications during treatment of hematuria in hemophilia A with epsilon-aminocaproic acid (EACA)]. Pol Tyg Lek 1971; 26 (4) 145-147
• 71 Bergin JJ. The complications of therapy with epsilon-aminocaproic acid. Med Clin North Am 1966; 50 (6) 1669-1678
• 72 Galassi G, Gibertoni M, Corradini L, Colombo A. Why may epsilon-aminocaproic acid (EACA) induce myopathy in man? Report of a case and literature review. Ital J Neurol Sci 1983; 4 (4) 489-492
• 73 Biswas CK, Milligan DA, Agte SD, Kenward DH, Tilley PJ. Acute renal failure and myopathy after treatment with aminocaproic acid. BMJ 1980; 281 (6233) 115-116
• 74 Colwell Jr CW, Chelly JE, Murkin JM , et al. Randomized study of aprotinin effect on transfusions and blood loss in primary THA. Clin Orthop Relat Res 2007; 465: 189-195
• 75 Petsatodis G, Samoladas E, Christodoulou A, Hatzokos I, Pournaras I. Does aprotinin reduce blood loss in total hip arthroplasty?. Orthopedics 2006; 29 (1) 75-77
• 76 Kokoszka A, Kuflik P, Bitan F, Casden A, Neuwirth M. Evidence-based review of the role of aprotinin in blood conservation during orthopaedic surgery. J Bone Joint Surg Am 2005; 87 (5) 1129-1136
• 77 Jeserschek R, Clar H, Aigner C, Rehak P, Primus B, Windhager R. Reduction of blood loss using high-dose aprotinin in major orthopaedic surgery: a prospective, double-blind, randomised and placebo-controlled study. J Bone Joint Surg Br 2003; 85 (2) 174-177
• 78 Engel JM, Hohaus T, Ruwoldt R, Menges T, Jürgensen I, Hempelmann G. Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin. Anesth Analg 2001; 92 (3) 775-780
• 79 Fleischmann F, Matuschek C, Orth K , et al. Aprotinin and classic wound drainage are unnecessary in total hip replacement - a prospective randomized trial. Eur J Med Res 2011; 16 (1) 20-28
• 80 Kristeller JL, Roslund BP, Stahl RF. Benefits and risks of aprotinin use during cardiac surgery. Pharmacotherapy 2008; 28 (1) 112-124
• 81 Slaughter TF, Greenberg CS. Antifibrinolytic drugs and perioperative hemostasis. Am J Hematol 1997; 56 (1) 32-36
• 82 Akizuki S, Yasukawa Y, Takizawa T. A new method of hemostasis for cementless total knee arthroplasty. Bull Hosp Jt Dis 1997; 56 (4) 222-224
• 83 Kluba T, Fiedler K, Kunze B, Ipach I, Suckel A. Fibrin sealants in orthopaedic surgery: practical experiences derived from use of QUIXIL® in total knee arthroplasty. Arch Orthop Trauma Surg 2012; 132 (8) 1147-1152
• 84 Massin P, Scemama C, Jeanrot C, Boyer P. Does fibrin sealant use in total knee replacement reduce transfusion rates? A non-randomised comparative study. Orthop Traumatol Surg Res 2012; 98 (2) 180-185
• 85 Skovgaard C, Holm B, Troelsen A , et al. No effect of fibrin sealant on drain output or functional recovery following simultaneous bilateral total knee arthroplasty: a randomized, double-blind, placebo-controlled study. Acta Orthop 2013; 84 (2) 153-158
• 86 Beierlein W, Scheule AM, Antoniadis G, Braun C, Schosser R. An immediate, allergic skin reaction to aprotinin after reexposure to fibrin sealant. Transfusion 2000; 40 (3) 302-305
• 87 Patel S, Rodriguez-Merchan EC, Haddad FS. The use of fibrin glue in surgery of the knee. J Bone Joint Surg Br 2010; 92 (10) 1325-1331
• 88 Hino M, Ishiko O, Honda KI , et al. Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery. Br J Haematol 2000; 108 (1) 194-195
• 89 Morita Y, Nishii O, Kido M, Tsutsumi O. Parvovirus infection after laparoscopic hysterectomy using fibrin glue hemostasis. Obstet Gynecol 2000; 95 (6 Pt 2) 1026
• 90 Honda K, Ishiko O, Tsujimura A , et al. Neutropenia accompanying parvovirus B19 infection after gynecologic surgery. Acta Haematol 2000; 103 (4) 186-190
• 91 Horowitz B, Busch M. Estimating the pathogen safety of manufactured human plasma products: application to fibrin sealants and to thrombin. Transfusion 2008; 48 (8) 1739-1753
• 92 Kusuma SK, Sheridan KC, Wasielewski RC. Use of bovine thrombin to reduce blood loss in primary total knee arthroplasty: a controlled randomized trial. J Arthroplasty 2013; (Mar) 18
• 93 Kim HJ, Fraser MR, Kahn B, Lyman S, Figgie MP. The efficacy of a thrombin-based hemostatic agent in unilateral total knee arthroplasty: a randomized controlled trial. J Bone Joint Surg Am 2012; 94 (13) 1160-1165
• 94 Gasparini G, Papaleo P, Pola P, Cerciello S, Pola E, Fabbriciani C. Local infusion of norepinephrine reduces blood losses and need of transfusion in total knee arthroplasty. Int Orthop 2006; 30 (4) 253-256
• 95 Malone KJ, Matuszak S, Mayo D, Greene P. The effect of intra-articular epinephrine lavage on blood loss following total knee arthroplasty. Orthopedics 2009; 32 (2) 100
• 96 Mazzocca AD, Meneghini RM, Chhablani R, Badrinath SK, Cole BJ, Bush-Joseph CA. Epinephrine-induced pulmonary edema during arthroscopic knee surgery. A case report. J Bone Joint Surg Am 2003; 85-A (5) 913-915
• 97 Yamada K, Imaizumi T, Uemura M, Takada N, Kim Y. Comparison between 1-hour and 24-hour drain clamping using diluted epinephrine solution after total knee arthroplasty. J Arthroplasty 2001; 16 (4) 458-462